4257-92-5O=C1N[C@@H](Cc2cnc[nH]2)C(=O)N2CCCC[C@@H]12LCXWQHWWTPOAFI-UWVGGRQHSA-Nbiologically active cpd to which thyrotropin-releasing hormone (TRH) is metabolized; structure; RN given refers to cpd without isomeric designation
4257-92-5、53109-32-3Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects.
No reaction records under the current filter.
Loading…